Melissa M. Frangie Data-verified
Affiliation confirmed via AI analysis of OpenAlex, ORCID, and web sources.
Researcher
unknown
Research Areas
Biography and Research Information
OverviewAI-generated summary
Melissa M. Frangie's research focuses on the development and evaluation of novel chemical compounds with potential therapeutic applications. Her work includes the synthesis and testing of pyrazole derivatives as antibacterial agents, specifically targeting Gram-positive bacteria such as Staphylococcus aureus. Frangie has also investigated the antimelanoma activities of chimeric thiazole–androstenone derivatives. Her scholarship metrics include an h-index of 2, with 2 total publications and 35 total citations. She has collaborated with researchers from Arkansas State University, including Mohammad A. Alam and Alexei G. Basnakian, as well as Alena V. Savenka from the National Center for Toxicological Research and Mark S. Smeltzer from the University of Arkansas for Medical Sciences.
Metrics
- h-index: 2
- Publications: 2
- Citations: 37
Selected Publications
-
Antimelanoma activities of chimeric thiazole–androstenone derivatives (2021)
-
4-4-(Anilinomethyl)-3-[4-(trifluoromethyl)phenyl]-1H-pyrazol-1-ylbenzoic acid derivatives as potent anti-gram-positive bacterial agents (2021)
Collaboration Network
Top Collaborators
- 4-4-(Anilinomethyl)-3-[4-(trifluoromethyl)phenyl]-1H-pyrazol-1-ylbenzoic acid derivatives as potent anti-gram-positive bacterial agents
- Antimelanoma activities of chimeric thiazole–androstenone derivatives
- 4-4-(Anilinomethyl)-3-[4-(trifluoromethyl)phenyl]-1H-pyrazol-1-ylbenzoic acid derivatives as potent anti-gram-positive bacterial agents
- Antimelanoma activities of chimeric thiazole–androstenone derivatives
- 4-4-(Anilinomethyl)-3-[4-(trifluoromethyl)phenyl]-1H-pyrazol-1-ylbenzoic acid derivatives as potent anti-gram-positive bacterial agents
- Antimelanoma activities of chimeric thiazole–androstenone derivatives
- 4-4-(Anilinomethyl)-3-[4-(trifluoromethyl)phenyl]-1H-pyrazol-1-ylbenzoic acid derivatives as potent anti-gram-positive bacterial agents
- 4-4-(Anilinomethyl)-3-[4-(trifluoromethyl)phenyl]-1H-pyrazol-1-ylbenzoic acid derivatives as potent anti-gram-positive bacterial agents
- 4-4-(Anilinomethyl)-3-[4-(trifluoromethyl)phenyl]-1H-pyrazol-1-ylbenzoic acid derivatives as potent anti-gram-positive bacterial agents
- 4-4-(Anilinomethyl)-3-[4-(trifluoromethyl)phenyl]-1H-pyrazol-1-ylbenzoic acid derivatives as potent anti-gram-positive bacterial agents
- 4-4-(Anilinomethyl)-3-[4-(trifluoromethyl)phenyl]-1H-pyrazol-1-ylbenzoic acid derivatives as potent anti-gram-positive bacterial agents
- 4-4-(Anilinomethyl)-3-[4-(trifluoromethyl)phenyl]-1H-pyrazol-1-ylbenzoic acid derivatives as potent anti-gram-positive bacterial agents
- Antimelanoma activities of chimeric thiazole–androstenone derivatives
- Antimelanoma activities of chimeric thiazole–androstenone derivatives
Similar Researchers
Based on overlapping research topics